GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » Debt-to-Asset

Visioneering Technologies (ASX:VTI) Debt-to-Asset : 0.00 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies Debt-to-Asset?

Visioneering Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. Visioneering Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. Visioneering Technologies's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was A$11.42 Mil. Visioneering Technologies's debt to asset for the quarter that ended in Dec. 2023 was 0.00.


Visioneering Technologies Debt-to-Asset Historical Data

The historical data trend for Visioneering Technologies's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies Debt-to-Asset Chart

Visioneering Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial 0.49 0.78 0.18 0.13 -

Visioneering Technologies Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.24 0.13 0.14 -

Competitive Comparison of Visioneering Technologies's Debt-to-Asset

For the Medical Devices subindustry, Visioneering Technologies's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visioneering Technologies's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's Debt-to-Asset falls into.



Visioneering Technologies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Visioneering Technologies's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Visioneering Technologies's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visioneering Technologies  (ASX:VTI) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Visioneering Technologies Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Visioneering Technologies (ASX:VTI) Business Description

Traded in Other Exchanges
N/A
Address
10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.

Visioneering Technologies (ASX:VTI) Headlines

From GuruFocus

Top 5 3rd Quarter Trades of VISTA CAPITAL PARTNERS, INC.

By GuruFocus Research GuruFocus Editor 11-08-2022

Top 5 4th Quarter Trades of Peterson Wealth Advisors, LLC

By GuruFocus Research GuruFocus Editor 01-21-2023

Ellevest, Inc.'s Top 5 Buys of the 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-02-2022

Top 5 3rd Quarter Trades of Gibson Wealth Advisors LLC

By GuruFocus Research GuruFocus Editor 11-23-2022

Top 5 4th Quarter Trades of Spectrum Planning & Advisory Services Inc.

By GuruFocus Research GuruFocus Editor 01-20-2023

Northstar Group, Inc. Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-26-2023

GP Brinson Investments LLC Buys 4, Sells 1 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-06-2023

Top 5 4th Quarter Trades of Novo Holdings A/S

By GuruFocus Research GuruFocus Editor 02-18-2023

Top 5 4th Quarter Trades of Parisi Gray Wealth Management

By GuruFocus Research GuruFocus Editor 01-24-2023

MITCHELL MCLEOD PUGH & WILLIAMS INC's Top 5 Buys of the 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-18-2022